| Title |
Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho‐pulmonary disease
|
|---|---|
| Published in |
Cochrane database of systematic reviews, May 2013
|
| DOI | 10.1002/14651858.cd003124.pub4 |
| Pubmed ID | |
| Authors |
Martin Chalumeau, Yvonne CM Duijvestijn |
| Abstract |
Acetylcysteine and carbocysteine are the most commonly prescribed mucolytic drugs in Brazil and many European and African countries. To our knowledge, no systematic review has been published on their efficacy and safety for acute upper and lower respiratory tract infections (RTIs) in children without chronic broncho-pulmonary disease. |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 19% |
| Colombia | 1 | 6% |
| Namibia | 1 | 6% |
| United Kingdom | 1 | 6% |
| Unknown | 10 | 63% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 81% |
| Practitioners (doctors, other healthcare professionals) | 1 | 6% |
| Scientists | 1 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 218 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 3 | 1% |
| Czechia | 1 | <1% |
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 211 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 32 | 15% |
| Other | 27 | 12% |
| Student > Ph. D. Student | 22 | 10% |
| Researcher | 20 | 9% |
| Student > Bachelor | 18 | 8% |
| Other | 38 | 17% |
| Unknown | 61 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 66 | 30% |
| Nursing and Health Professions | 20 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 19 | 9% |
| Psychology | 11 | 5% |
| Unspecified | 7 | 3% |
| Other | 21 | 10% |
| Unknown | 74 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2023.
All research outputs
#1,240,032
of 25,827,956 outputs
Outputs from Cochrane database of systematic reviews
#2,490
of 13,135 outputs
Outputs of similar age
#9,795
of 208,104 outputs
Outputs of similar age from Cochrane database of systematic reviews
#48
of 284 outputs
Altmetric has tracked 25,827,956 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,135 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.3. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 208,104 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 284 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.